Innovent Biologics CEO on Pharma Industry, Prices, Pipeline, Cancer Cure

The video discusses the growth and investment in China's pharmaceutical industry, highlighting the government's significant spending and the industry's productivity. It addresses the high cost of drugs in China compared to the US and efforts to reduce these costs through tax reductions and increased competition. The impact of price wars on pharmaceutical companies is explored, along with the potential entry of Indian companies into the Chinese market. The video also covers R&D investments, the future of cancer treatment, and the influence of China's aging population on healthcare demand.

What is the significance of the price war in the pharmaceutical market?

How does the R&D pipeline of the company reflect its future prospects?

What are the expectations for the future of cancer treatment in relation to Chinese pharmaceutical companies?